Valuation — not yet established
No valuation for Locus Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($35.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·Watchlist + deal alerts for Locus Biosciences
Create free account
No card required
Funding history
6 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2022 | Later Stage VC (Series B) | $35.0M | ▮ | ▮ |
| Apr 2020 | Debt | $20.0M | ▮ | ▮ |
| Jul 2018 | Early Stage VC | $7.0M | ▮ | ▮ |
| Sep 2017 | Early Stage VC | $7.0M | ▮ | ▮ |
| Dec 2016 | Debt | $350K | ▮ | ▮ |
| Jan 2016 | Seed Round | $1.3M | ▮ | ▮ |
How Locus Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Locus Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Locus Biosciences raised?
- Locus Biosciences has raised $35.0M in total funding across 6 recorded rounds.
- When did Locus Biosciences last raise?
- Locus Biosciences last raised in May 2022 (Later Stage VC (Series B)), raising $35.0M.